Regulations.gov document
TAB A-2017-723-NSURE-PRIA RE Memorandum - Nonprescription Drug Product With an Additional…
Supporting & Related Material · FDA-2021-N-0862 · posted Jan 20, 2023
Key facts
| Document ID | FDA-2021-N-0862-0201 |
|---|---|
| Title | TAB A-2017-723-NSURE-PRIA RE Memorandum - Nonprescription Drug Product With an Additional Condition for Nonprescription Use (Proposed Rule); Publication Date: June 28, 2022 |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2021-N-0862 |
| Posted | Jan 20, 2023 |
At a glance
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: